Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

MRC WIMM were honoured to host a celebration marking this year’s Nobel Prize in Physiology or Medicine, awarded to their alumnus Sir Peter Ratcliffe.

“How is it that I came to be in this rather fortunate position” were the opening words by Sir Peter Ratcliffe, winner of this year’s Nobel Prize in Physiology or Medicine. The speech was part of a celebration hosted at the MRC WIMM on Monday 21 October, the anniversary of Alfred Nobel’s birth.

Attended by over 300 people, the party was an opportunity to celebrate Sir Peter Ratcliffe’s achievements, not only scientific but also his efforts to support and foster the scientific and medical community in Oxford. Sir John Bell, Regius Professor of Medicine at the University of Oxford, thanked Sir Peter for his contributions over the years to the Medical School, the MRC WIMM and the Nuffield Department of Medicine, and lauded him as a “real clinician scientist”. These sentiments were echoed by Prof Richard Cornall, Head of the Nuffield Department of Medicine, a position previously occupied by Sir Peter.

Read more (MRC WIMM website)

Similar stories

Oxford joins forces with 11 universities to launch social impact investment fund

The University of Oxford has joined forces with 11 leading universities to create Impact 12, an impact investment fund to support mission-led university ventures.

Potential for radiotherapy and VTP multimodality therapy for prostate cancer

A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Oxford University and partners win government funding to evaluate Paige Prostate Cancer Detection System

A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University as part of a successful NHSx Artificial Intelligence Health and Care Award application.